Syngene Boosts Biologics Manufacturing Capability Following Impressive Q1 Performance

Syngene International Limited has demonstrated a stellar start to the fiscal year with a 26% YoY surge in both revenues and profit after tax. This strong Q1 performance sets the stage for the company’s strategic expansion plans. In a significant…